-
SGLT Related Products (27)
Related Products (27)
- 1
- 2
-
Ertugliflozin-d5
0 ImagesCat. No.: HY-15461SCAS No.: 1298086-22-2Synonyms: PF-04971729-d5Ertugliflozin-d5 is the deuterium labeled Ertugliflozin. Ertugliflozin (PF-04971729) is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2. Has the potential for the treatment of type 2 diabetes mellitus.
-
Remogliflozin etabonate-d7
0 ImagesCat. No.: HY-166548SCAS No.: 1233515-93-9Synonyms: GSK189075-d7Remogliflozin etabonate-d7 (GSK189075-d7) is the deuterium labeled Remogliflozin etabonate. Remogliflozin etabonate (GSK189075) is an orally active, selective and low-affinity sodium glucose cotransporter (SGLT2) inhibitor with Ki values of 1.95 μM, 2.14 μM, 43.1 μM, 8.57 μM for hSGLT2, rSGLT2, hSGLT1, rSGLT1, respectively. Remogliflozin etabonate is a proagent based on benzylpyrazole glucoside and is metabolized to its active form, Remogliflozin, in the body. Remogliflozin etabonate exhibits antidiabetic efficacy in rodent models.
-
Velagliflozin proline (Standard)
0 ImagesCat. No.: HY-109018ARCAS No.: 1539295-26-5Velagliflozin proline (Standard) is the analytical standard of Velagliflozin (proline) (HY-109018A). This product is intended for research and analytical applications. Velagliflozin proline is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor with antidiabetic activity. Velagliflozin proline reduces renal glucose reabsorption and stimulates glycosuria, which lowers blood sugar and insulin concentrations.
-
Empagliflozin-d6
0 ImagesCat. No.: HY-15409S2Synonyms: BI 10773-d6Empagliflozin-d6 (BI 10773-d6) is deuterium labeled Empagliflozin. Empagliflozin (BI 107730 is a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor with an IC50 of 3.1 nM for human SGLT-2.
-
Luseogliflozin (Standard)
0 ImagesCat. No.: HY-10449RCAS No.: 898537-18-3Synonyms: TS 071 (Standard)Luseogliflozin (Standard) is the analytical standard of Luseogliflozin (HY-10449). This product is intended for research and analytical applications. Luseogliflozin (TS 071) is a potent, selective, orally active sodium-dependent glucose cotransporter (SGLT) 2 inhibitor, with an IC50 of 2.26 nM, about 1765-fold selectivity over SGLT1 (IC50, 3990 nM). Luseogliflozin has the protential for researching type 2 diabetes.
-
Velagliflozin (Standard)
0 ImagesCat. No.: HY-109018RCAS No.: 946525-65-1Velagliflozin (Standard) is the analytical standard of Velagliflozin (HY-109018). This product is intended for research and analytical applications. Velagliflozin is an orally available sodium-glucose cotransporter 2 (SGLT2) inhibitor, with anti-diabetic activity.
-
Olorigliflozin
0 ImagesCat. No.: HY-168989CAS No.: 2035989-50-3Olorigliflozin is a sodium glucose co-transporter inhibitor with anti-hyperglycemic effects.
- 1
- 2
